Efforts to supply the first CBD product to Brazil’s public healthcare system will have to wait a while longer – and there is some dispute between the institute preparing to produce it and the sponsors of a Congress bill
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields